📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Kanyos

1.1 - Company Overview

Kanyos Logo

Kanyos

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of antigen-specific immune tolerance technology focused on two autoimmune indications: type 1 diabetes and celiac disease. Technology originated at EPFL in Switzerland and is being developed in collaboration with sister company Anokion.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Kanyos

Cell IDx Logo

Cell IDx

HQ: United States Website
  • Description: Provider of multiplexed cellular immunodiagnostics solutions, developing highly sensitive and specific reagents for research and clinical immunohistochemistry, and offering UltraPlex technology for multiplex chromogenic and fluorescent tissue staining suitable for high-throughput biomarker tissue profiling.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cell IDx company profile →
Apitope Logo

Apitope

HQ: United Kingdom Website
  • Description: Provider of discovery and development of disease-modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis; first product candidate licensed to Merck Serono.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apitope company profile →
Hansa Biopharma Logo

Hansa Biopharma

HQ: Sweden Website
  • Description: Provider of immunomodulatory treatments for rare immunological diseases, including Imlifidase, a first-generation IgG-cleaving enzyme for rapid inactivation of IgG antibodies via single intravenous treatment. Offers a proprietary enzyme technology platform targeting pathogenic antibodies across transplantation, autoimmunity, gene therapy and oncology, supported by strategic partnerships and sustainability initiatives.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hansa Biopharma company profile →
Noveome Biotherapeutics Logo

Noveome Biotherapeutics

HQ: United States Website
  • Description: Provider of regenerative repair therapies for inflamed or damaged tissues via ST266, a multi-targeted secretome of biologically active proteins for neuroprotection, inflammation modulation, cell recovery, and healing in ophthalmology, neurology, and dermatology; explored in PEDs, optic neuritis, glaucoma (Phase I), NEC, and COVID-19/sepsis cytokine storm.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Noveome Biotherapeutics company profile →
Allakos Logo

Allakos

HQ: United States Website
  • Description: Provider of therapeutic antibodies for allergy, inflammatory and proliferative diseases, including AK006, a humanized IgG1 monoclonal antibody targeting Siglec-6 to inhibit mast cell activation and reduce mast cell numbers via antibody-dependent cellular phagocytosis, and AK007, a humanized Siglec-10 antagonist that blocks ligand interaction to restore macrophage and dendritic cell anti-tumor activity and promote anti-tumor immunity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Allakos company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Kanyos

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Kanyos

2.2 - Growth funds investing in similar companies to Kanyos

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Kanyos

4.2 - Public trading comparable groups for Kanyos

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Kanyos

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Kanyos

What does Kanyos do?

Kanyos is a provider of antigen-specific immune tolerance technology focused on two autoimmune indications: type 1 diabetes and celiac disease. Technology originated at EPFL in Switzerland and is being developed in collaboration with sister company Anokion.

Who are Kanyos's competitors?

Kanyos's competitors and similar companies include Cell IDx, Apitope, Hansa Biopharma, Noveome Biotherapeutics, and Allakos.

Where is Kanyos headquartered?

Kanyos is headquartered in United States.

How many employees does Kanyos have?

Kanyos has 1,000 employees 🔒.

When was Kanyos founded?

Kanyos was founded in 2010 🔒.

What sector and industry vertical is Kanyos in?

Kanyos is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Kanyos

Who are the top strategic acquirers in Kanyos's sector and industry

Top strategic M&A buyers and acquirers in Kanyos's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Kanyos?

Top strategic M&A buyers groups and sectors for Kanyos include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Kanyos's sector and industry vertical

Which are the top PE firms investing in Kanyos's sector and industry vertical?

Top PE firms investing in Kanyos's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Kanyos's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Kanyos's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Kanyos's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Kanyos include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Kanyos's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Kanyos?

The key public trading comparables and valuation benchmarks for Kanyos include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Kanyos for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Kanyos with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Kanyos's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Kanyos with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Kanyos's' sector and industry vertical?

Access recent funding rounds and capital raises in Kanyos's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Kanyos